STOCK TITAN

Cytokinetics CEO Robert I. Blum sells 7,500 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

CYTOKINETICS INC (CYTK) President & CEO Robert I. Blum exercised options for 7,500 common shares on November 16, 2026, at an exercise price of $10.60 per share. On the same date, he sold 5,077 shares at a weighted-average $53.22, 2,223 shares at $54.08, and 200 shares at $55.21. The transactions were reported under a Rule 10b5-1 plan. His reported option position after the exercise was 126,745 shares. Separate holdings included 2,083 shares in each of The Bridget Blum 2003 Irrevocable Trust and The Brittany Blum 2003 Irrevocable Trust; Blum disclaimed beneficial ownership in both.

Insider Blum Robert I
Role President & CEO
Sold 7,500 shs ($401K)
Approx. gross sale proceeds $401K
Approx. exercise cost $80K
Approx. pre-tax spread $322K
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (Right to Buy) 7,500 $0.00 $0.00
Exercise Common Stock 7,500 $10.60 $80K
Sale Common Stock F1 5,077 $53.22 $270K
Sale Common Stock F2 2,223 $54.08 $120K
Sale Common Stock F3 200 $55.21 $11K
Holding Common Stock F4 -- -- --
Holding Common Stock F5 -- -- --
Holding Common Stock -- -- --
Holdings After Transaction: Non-Qualified Stock Option (Right to Buy) — 126,745 options (Direct); Common Stock — 278,544 shares (Direct); Common Stock — 2,083 shares (Indirect, by Trust 1. Beneficial Ownership disclaimed.); Common Stock — 2,083 shares (Indirect, by Trust 2. Beneficial Ownership Disclaimed.); Common Stock — 0 shares (Indirect, by Trust 3. Beneficial Ownership Disclaimed.)
Footnotes (5)
  1. F1. The reported transaction involves sale transactions from $52.80 to $53.80 per share. The weighted average price per share was $53.22. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price
  2. F2. The reported transaction involves sale transactions from $53.80 to $54.46 per share. The weighted average price per share was $54.08. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price
  3. F3. The reported transaction involves sale transactions from $54.94 to $55.59 per share. The weighted average price per share was $55.21. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price
  4. F4. Shares held by The Bridget Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
  5. F5. Shares held by The Brittany Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
Options exercised 7,500 shares November 16, 2026
Exercise price $10.60 per share Options exercised November 16, 2026
Shares sold 5,077 shares Weighted-average sale price of $53.22 per share on November 16, 2026
Shares sold 2,223 shares Weighted-average sale price of $54.08 per share on November 16, 2026
Shares sold 200 shares Weighted-average sale price of $55.21 per share on November 16, 2026
Options after exercise 126,745 shares Reported position following the November 16, 2026 exercise
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (Right to Buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Rule 10b5-1 plan regulatory
"Transactions reported under a Rule 10b5-1 plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average price per share financial
"The weighted average price per share was $53.22"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CYTK shares did Robert I. Blum sell, and at what prices?

Robert I. Blum sold 7,500 shares in three reported tranches on November 16, 2026: 5,077 at a weighted-average $53.22, 2,223 at $54.08, and 200 at $55.21. The sales were reported under a Rule 10b5-1 plan.

How many CYTK shares did Robert I. Blum acquire through options?

He exercised options for 7,500 common shares on November 16, 2026, at an exercise price of $10.60 per share. His reported option position following the exercise was 126,745 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Blum Robert I

(Last)(First)(Middle)
350 OYSTER POINT BLVD

(Street)
SOUTH SAN FRANCISCO CALIFORNIA 94080

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CYTOKINETICS INC [ CYTK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President & CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/16/2026M7,500A$10.6286,044D
Common Stock11/16/2026S5,077D$53.22(1)280,967D
Common Stock11/16/2026S2,223D$54.08(2)278,744D
Common Stock11/16/2026S200D$55.21(3)278,544D
Common Stock2,083Iby Trust 1. Beneficial Ownership disclaimed.(4)
Common Stock2,083Iby Trust 2. Beneficial Ownership Disclaimed.(5)
Common Stock0Iby Trust 3. Beneficial Ownership Disclaimed.
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (Right to Buy)$10.611/16/2026M7,50003/28/201702/28/2027Common Stock7,500$0126,745D
Explanation of Responses:
1. The reported transaction involves sale transactions from $52.80 to $53.80 per share. The weighted average price per share was $53.22. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price
2. The reported transaction involves sale transactions from $53.80 to $54.46 per share. The weighted average price per share was $54.08. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price
3. The reported transaction involves sale transactions from $54.94 to $55.59 per share. The weighted average price per share was $55.21. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price
4. Shares held by The Bridget Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
5. Shares held by The Brittany Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
/s/ Jeff Hessekiel, attorney-in-fact for Mr. Blum11/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading